Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma.
Zhicheng WuQiu WangXiuqing LiuJiantong ZhengLing JiXiaofeng LiPublished in: Journal of oncology (2022)
A novel multiomics prognostic signature of EC was identified and validated in this study, which could guide clinical management of EC and benefit personalized immunotherapy.